EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients
EOS789 是一种广谱磷酸盐转运抑制剂,在血液透析患者的 1b 期随机交叉试验中显示出安全性和疗效。
期刊:Kidney International
影响因子:12.6
doi:10.1016/j.kint.2020.09.035
Hill Gallant, Kathleen M; Stremke, Elizabeth R; Trevino, Laurie L; Moorthi, Ranjani N; Doshi, Simit; Wastney, Meryl E; Hisada, Nozomi; Sato, Jotaro; Ogita, Yoshitaka; Fujii, Naohisa; Matsuda, Yuya; Kake, Takei; Moe, Sharon M